Back to search
Complicated Intra-abdominal Infections (cIAI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Complicated Intra-abdominal Infections (cIAI) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Complicated Intra-abdominal Infections (cIAI) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A Phase 2 trial to assess safety, tolerability, and pharmacokinetics of eravacycline in pediatric patients aged 8 to \<18 years with cIAI.
The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacte…
Complicated intra-abdominal infection (cIAI) triggers dysregulated systemic inflammation and immune paralysis leading to high organ failure and death risk. Ulin…
The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 m…